InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Coen Stacy Ann, Directrice des Affaires. Director active across 1 companies, notably ImmunoGen, Inc.. Cumulatively, 4 reports have been logged. The latest transaction was filed on 31 December 2021 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations4 total
€7,3971,496 shares@ €4.944840.5% of flow
Common Stock
SEC:0001179110-22-000102·
€7,3971,496 shares@ €4.944820.3% of flow
Common Stock
SEC:0001179110-22-000102:0·
€10,8472,330 shares@ €4.655659.5% of flow
Common Stock
SEC:0001179110-21-007316·
€10,8472,330 shares@ €4.655629.7% of flow
Common Stock
SEC:0001179110-21-007316:0·
4 of 4 declarations
About Coen Stacy Ann
Stacy Ann Coen is the Chief Business Officer at ImmunoGen, Inc. She is responsible for the company's business strategy, overseeing growth and development initiatives. Her role is essential for ensuring the success of the organization.
